Latest from Anabel Costa-Ferreira
New general texts to be published in the European Pharmacopoeia in July 2025 are intended to support the rapidly developing mRNA vaccine field, which become an increasingly important technology in recent years.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. 65 documents have been posted on the tracker since its last update.
The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.
Many of the recommendations listed in a new report, which aims to prepare the European medicines regulatory network (EMRN) for Alzheimer’s disease development challenges, will form part of EMRN’s future plans.
The complex landscape of clinical trials, fraught with pressures and risks, and exacerbated by the adoption of new technologies, regulatory burdens, and drug pricing negotiations, is rebounding with aplomb.